Functional Characterization of Neural-Restrictive Silencer Element in Mouse Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Gene Expression

被引:4
|
作者
Sugawara, Hideki [1 ,2 ]
Tominaga, Aiko [1 ]
Inoue, Kazuhiko [1 ]
Takeda, Yasuo [2 ]
Yamada, Katsushi [2 ]
Miyata, Atsuro [1 ]
机构
[1] Kagoshima Univ, Dept Pharmacol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan
关键词
Pituitary adenylate cyclase-activating polypeptide (PACAP); Neural-restrictive silencer element (NRSE); PC12; Trichostatin A (TSA); Luciferase reporter assay; Electrophoretic mobility shift assay (EMSA); SODIUM-CHANNEL GENE; TARGET GENES; REST; IDENTIFICATION; ORGANIZATION; REPRESSOR; PROTEIN; CELLS;
D O I
10.1007/s12031-014-0348-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pituitary adenylate cyclase-activating polypeptide (PACAP) is predominantly localized in the nervous system, but the underlying mechanism in its neuron-specific expression remains unclear. In addition to two neural-restrictive silencer-like element (NRSLE1 and 2), as reported previously, we have identified the third element in -1,601 to -1,581 bp from the translational initiation site of mouse PACAP gene and termed it as NRSLE3, of which, the sequence and location were highly conserved among mouse, rat, and human PACAP genes. In luciferase reporter assay, the deletion or site-directed mutagenesis of NRSLE3 in the reporter gene construct, driven by heterologous SV40 promoter, cancelled the repression of luciferase activity in non-neuronal Swiss-3T3 cells. Furthermore, its promoter activity was significantly repressed in Swiss-3T3 cells, but not in neuronal-differentiated PC12 cells. The electrophoretic mobility shift assay (EMSA) with nuclear extracts of Swiss-3T3 cells demonstrated a specific complex with NRSLE3 probe that exhibited the same migration with the neural-restrictive silencer element (NRSE) probe of rat type II sodium channel gene. During neuronal differentiation of PC12 cells, the increment of PACAP mRNA exhibited the correlation with that of REST4 mRNA, which is a neuron-specific variant form of neural-restrictive silencer factor (NRSF). In undifferentiated PC12 cells, trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, which indirectly inhibits NRSF-mediated gene silencing, increased PACAP mRNA level and attenuated the repression of promoter activity of 5' flanking region of mouse PACAP gene containing NRSLEs. These suggest that the NRSE-NRSF system implicates in the regulatory mechanism of neuron-specific expression of PACAP gene.
引用
收藏
页码:526 / 534
页数:9
相关论文
共 50 条
  • [31] Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: Actions on the anterior pituitary gland
    Rawlings, SR
    Hezareh, M
    ENDOCRINE REVIEWS, 1996, 17 (01) : 4 - 29
  • [32] Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland
    Mazzocchi, G
    Malendowicz, LK
    Neri, G
    Andreis, PG
    Ziolkowska, A
    Gottardo, L
    Nowak, KW
    Nussdorfer, GG
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 9 (03) : 233 - 243
  • [33] Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor isoforms in the rat uterus
    Lee, SH
    Kim, SI
    Kim, YK
    RECENT PROGRESS IN MOLECULAR AND COMPARATIVE ENDOCRINOLOGY, 1999, : 123 - 128
  • [34] Pituitary adenylate cyclase-activating polypeptide (PACAP) is an upstream regulator of prodynorphin mRNA expression in neurons
    Dong, Ying Xu
    Fukuchi, Mamoru
    Inoue, Minami
    Takasaki, Ichiro
    Tabuchi, Akiko
    Wu, Chun Fu
    Tsuda, Masaaki
    NEUROSCIENCE LETTERS, 2010, 484 (03) : 174 - 177
  • [35] Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
    Seaborn, Tommy
    Masmoudi-Kouli, Olfa
    Fournier, Alain
    Vaudry, Hubert
    Vaudry, David
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (03) : 204 - 214
  • [36] The effect of pituitary adenylate cyclase-activating polypeptide (PACAP) in islet transplantation model
    Sakuma, Yasunaru
    Ricordi, Camillo
    Miki, Atsushi
    Yamamoto, Toshiyuki
    Mita, Atsuyoshi
    Barker, Scott
    Molano, Damaris
    Fornoni, Alessia
    Pileggi, Antonello
    Inverardi, Luca
    Yada, Toshihiko
    Yasuda, Yoshikazu
    Ichii, Hirohito
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 508 - 508
  • [37] Pituitary adenylate cyclase-activating polypeptide (PACAP) and insulin secretion: Effects and mechanisms
    Klinteberg, KAF
    Karlsson, S
    Moller, K
    Sundler, F
    Ahren, B
    VIP, PACAP, AND RELATED PEPTIDES, 2ND INTERNATIONAL SYMPOSIUM, 1996, 805 : 543 - 548
  • [38] The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily
    Sherwood, NM
    Krueckl, SL
    McRory, JE
    ENDOCRINE REVIEWS, 2000, 21 (06) : 619 - 670
  • [39] Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice
    Isaac, Emma R.
    Sherwood, Nancy M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 280 (1-2) : 13 - 19
  • [40] Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome
    Eneman, Benedicte
    Elmonem, Mohamed A.
    van den Heuvel, Lambertus P.
    Khodaparast, Laleh
    Khodaparast, Ladan
    van Geet, Chris
    Freson, Kathleen
    Levtchenko, Elena
    PLOS ONE, 2017, 12 (07):